CD274 and neoplasm: Response and resistance to ICIs are governed by various mechanisms, including PD-L1 expression, tumor mutation burden (TMB), mismatch repair pathways, microsatellite instability, oncogenic pathway expression, and the tumor microenvironment (4, 5).